Pelabresib

SI-6681

Pelabresib, >98% (HPLC)

CAS No. : [1380087-89-7]

Synonyms : CPI-0610

IUPAC Name : (S)-2-(6-(4-Chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Pelabresib selectively inhibits BET bromodomains, showing potent activity against BRD4‑BD1 (IC₅₀ = 39 nM) and suppressing MYC transcription (EC₅₀= 0.18 µM). Its oral bioavailability and strong cellular efficacy make it a valuable tool for BET‑dependent cancer research.

References : Albrecht B. K. et al.: J. Med. Chem., 59(4), 1330-9, 2016; Siu K. T. et al.: Leukemia., 31(8), 1760-1769, 2007.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.